Open AccessMycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome
Author(s) -
C Day
Publication year - 2002
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/17.11.2011
Subject(s) - medicine , nephrotic syndrome , prednisolone , focal segmental glomerulosclerosis , minimal change disease , gastroenterology , cyclophosphamide , mycophenolate , complete remission , glomerulonephritis , surgery , chemotherapy , transplantation , kidney
A small proportion of patients with initially steroid-sensitive nephrotic syndrome relapse frequently, despite treatment with cyclophosphamide and/or cyclosporin. We investigated the efficacy of mycophenolate mofetil (MMF) in this group.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom